A New Intra-Arterial DeliveryPlatform for Pro-Arteriogenic Compounds to Stimulate Collateral Artery Growth Via Transforming Growth Factor-β1 Release

Journal of the American College of Cardiology

Volumn 50, Issue 4, 2007, Pages 351-358

  Grundmann, Sebastian ^a   van Royen, Niels ^a   Pasterkamp, Gerard ^b   Gonzalez, Nieves ^c   Tijsma, Edze J ^c   Piek, Jan J ^a   Hoefer, Imo E ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMORAL ARTERY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; ILIAC ARTERY; NONHUMAN; PRIORITY JOURNAL; STENT;

ABSORBABLE IMPLANTS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; COLLATERAL CIRCULATION; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERS; RABBITS; STENTS; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME;

EID: 34447338588     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.03.046     Document Type: Article

References (25)

1. Ito W.D., Arras M., Winkler B., Scholz D., Schaper J., and Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80 (1997) 829-837
2. Rajanayagam M.A., Shou M., Thirumurti V., et al. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. J Am Coll Cardiol 35 (2000) 519-526
3. Lazarous D.F., Shou M., Stiber J.A., et al. Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. Cardiovasc Res 36 (1997) 78-85
4. Simons M., Annex B.H., Laham R.J., et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105 (2002) 788-793
5. van Royen N., Schirmer S.H., Atasever B., et al. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation 112 (2005) 1040-1046
6. Seiler C., Pohl T., Wustmann K., et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104 (2001) 2012-2017
7. Post M.J., Laham R., Sellke F.W., and Simons M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 49 (2001) 522-531
8. Dove A. Big pharmas seek biotechs that deliver. Nat Biotechnol 19 (2001) 398
9. van Royen N., Hoefer I., Buschmann I., et al. Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. Faseb J 16 (2002) 432-434
10. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8 (1997) 21-43
11. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., and ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J 21 (2002) 1743-1753
12. Hoefer I.E., Grundmann S., Schirmer S., et al. Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion. J Am Coll Cardiol 46 (2005) 994-1001
13. Fulton W.F.M. The Coronary Arteries (1965), Charles C Thomas, Springfield, IL
14. Grundmann S., Hoefer I., Ulusans S., et al. Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit. Am J Physiol Heart Circ Physiol 289 (2005) H1497-H1505
15. Schwartz R.S., Edelman E.R., Carter A., et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 106 (2002) 1867-1873
16. Zbinden S., Zbinden R., Meier P., Windecker S., and Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 46 (2005) 1636-1642
17. Srivastava S., Terjung R.L., and Yang H.T. Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 285 (2003) H1190-H1197
18. Simons M. Angiogenesis: where do we stand now?. Circulation 111 (2005) 1556-1566
19. Allen L.A., Terjung R.L., and Yang H.T. Exogenous basic fibroblast growth factor increases collateral blood flow in female rats with femoral artery occlusion. J Cardiovasc Pharmacol 47 (2006) 146-154
20. Schmidmaier G., Wildemann B., Stemberger A., Haas N.P., and Raschke M. Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 58 (2001) 449-455
21. Fuchs S., Shou M., Baffour R., Epstein S.E., and Kornowski R. Lack of correlation between angiographic grading of collateral and myocardial perfusion and function: implications for the assessment of angiogenic response. Coron Artery Dis 12 (2001) 173-178
22. Boengler K., Pipp F., Fernandez B., Ziegelhoeffer T., Schaper W., and Deindl E. Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp). Cardiovasc Res 59 (2003) 573-581
23. Hoefer I., van Royen N., Buschmann I., Piek J., and Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 49 (2001) 609-617
24. Meier P., Zbinden R., Togni M., et al. Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol 49 (2007) 15-20
25. Cipollone F., Fazia M., Mincione G., et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke 35 (2004) 2253-2257